You are here

Seelos Therapeutics

Seelos’ IV-administered sugar therapy fails to improve ALS severity in midstage trial

Fierce Biotech

Tue, 03/19/24 - 11:19 am

Seelos Therapeutics

clinical trials

Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon

BioSpace

Sun, 10/1/23 - 01:05 pm

BrainStorm Cell Therapeutics

Seelos Therapeutics

Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease

BioSpace

Mon, 07/24/23 - 09:57 am

neurodegenerative disease

Alzheimer's disease

Axsome Therapeutics

BrainStorm Cell Therapeutics

Seelos Therapeutics

Parkinson's Disease

Mitsubishi Tanabe Pharma

Huntington's disease

Prilenia Therapeutics

Seelos Therapeutics Files Paperwork for $14 Million Offering

CP WIre

Wed, 01/22/20 - 11:14 am

Seelos Therapeutics

Sanfillipo Syndrome

suicidal ideation

Seelos Therapeutics Files Paperwork for $14 Million Offering

Wed, 01/22/20 - 11:12 am

Seelos Therapeutics

Sanfillipo Syndrome

suicidal ideation